To investigate the potential prognostic value of TRIP13 in CRC, immunohistochemistry was performed with 200 CRC formalin-fixed, paraffin-embedded (FFPE) tumor slides with complete clinicopathological characteristics and follow-up data. This evidence concerns the gene TRIP13 and colorectal carcinoma.